Prehabilitation in patients with diabetes: targeting metabolic dysfunction to improve perioperative outcomes
Article information
Abstract
Patients with diabetes mellitus experience disproportionately worse postoperative outcomes, reflecting an underlying metabolic dysfunction that conventional perioperative optimization strategies fail to address. Although prehabilitation improves outcomes in selected surgical populations, its effectiveness in diabetes remains inconsistent, suggesting a mismatch between intervention strategies and the mechanisms driving perioperative risk. This review aimed to evaluate the role of metabolic dysfunction in perioperative risk among patients with diabetes and to propose a mechanism-informed prehabilitation framework targeting key metabolic disturbances. Evidence from clinical studies, systematic reviews, and perioperative guidelines was synthesized to develop a structured framework linking metabolic targets with targeted interventions within perioperative care pathways. Key metabolic disturbances, including insulin resistance, impaired metabolic flexibility, mitochondrial dysfunction, inflammation, and glycemic variability, amplify the surgical stress response and impair recovery in these patients. Conventional multimodal prehabilitation fails to adequately address these mechanisms. A targeted metabolic optimization approach incorporating exercise-based conditioning, nutritional optimization, glycemic management (including continuous glucose monitoring), and pharmacological modulation enables targeted interventions across these domains. Individualization strategies based on dominant metabolic features improve clinical applicability. The integration of this approach within perioperative pathways, including enhanced recovery after surgery (ERAS), provides a structured strategy to improve metabolic stability and perioperative resilience. Prehabilitation in patients with diabetes should shift from generalized multimodal strategies to targeted strategies involving metabolic optimization aligned with the underlying pathophysiology. A personalized and mechanism-informed approach integrated within the ERAS pathways may improve perioperative outcomes in this high-risk population. Prospective studies are needed to validate this strategy.
Introduction
Diabetes mellitus (DM) is one of the most important predictors of adverse postoperative outcomes, and its growing prevalence has become an increasing challenge in perioperative care. Patients with diabetes consistently experience higher rates of surgical site infections, impaired wound healing, cardiovascular complications, and prolonged hospitalization, reflecting a fundamentally altered physiological response to surgical stress [1–3]. These adverse outcomes are largely driven by diabetes-related metabolic dysfunction that reduces the physiological reserve and limits the ability to tolerate perioperative stress.
Prehabilitation has emerged as a strategy to improve preoperative readiness through targeted interventions such as exercise training and nutritional optimization [4–6]. Although these approaches have demonstrated benefits in selected surgical populations, such as those undergoing colorectal cancer surgery and major hepatectomy, their effectiveness in patients with diabetes remains inconsistent, with limited evidence supporting diabetes-specific adaptation [5–7]. This gap suggests that current prehabilitation strategies may not adequately address the mechanisms underlying increased perioperative risk in this population.
A key limitation to prehabilitation programs is that most are designed to improve overall functional capacity rather than address diabetes-related metabolic abnormalities. In patients with diabetes, perioperative vulnerability is closely related to impaired insulin signaling, reduced metabolic flexibility, mitochondrial dysfunction, chronic low-grade inflammation, and glycemic variability [8–11]. These disturbances amplify the metabolic response to surgical stress and promote hyperglycemia, inflammation, and catabolism that together contribute to delayed recovery and increased postoperative morbidity [11].
The targeting of these mechanisms, including insulin resistance, impaired metabolic flexibility, mitochondrial dysfunction, chronic inflammation, and glycemic variability, represents a critical opportunity to improve the effectiveness of prehabilitation in patients with diabetes. Exercise-based interventions improve insulin sensitivity and mitochondrial function, whereas nutritional strategies counteract anabolic resistance and preserve skeletal muscle mass [12–15]. Advances in perioperative glycemic management, particularly continuous glucose monitoring (CGM), allow for improved detection of glycemic excursions and may enhance metabolic stability [16–18]. In addition, pharmacological modulation, including with agents such as metformin, may influence key metabolic pathways, although their role in the perioperative setting remains unclear [19].
Accordingly, this review focuses on prehabilitation strategies in patients with diabetes by targeting metabolic dysfunction. We propose a clinically oriented and mechanism-informed framework in which perioperative interventions are aligned with key metabolic disturbances. By integrating targeted metabolic strategies into perioperative care, this approach aims to enhance physiological resilience and improve surgical outcomes in patients with diabetes (Fig. 1).
Mechanism-based framework for targeted metabolic optimization in diabetes-specific prehabilitation. Patients with diabetes exhibit baseline metabolic vulnerability that is further exacerbated by the surgical stress response, leading to metabolic dysfunction. Alignment of targeted interventions with these metabolic disturbances enhances physiological resilience and improves postoperative outcomes. This approach can be integrated within enhanced recovery after surgery (ERAS) pathways to support structured perioperative metabolic optimization.
Materials and Methods
Literature search and study selection
A structured literature search was conducted using the PubMed/MEDLINE database to identify studies relevant to prehabilitation and perioperative metabolic optimization in patients with diabetes. Articles published in English between January 2005 and December 2025 were included to reflect currently adopted enhanced recovery after surgery (ERAS) practices and modern prehabilitation strategies.
The search terms were combined using Boolean operators and included “prehabilitation,” “diabetes mellitus,” “metabolic optimization,” and “enhanced recovery after surgery,” along with related terms such as “exercise,” “nutrition,” “glycemic control,” and “continuous glucose monitoring.” The reference lists of key reviews, clinical guidelines, and landmark trials were screened to identify relevant studies.
The eligible studies included randomized controlled trials, observational cohort studies, systematic reviews, meta-analyses, and international clinical practice guidelines that address perioperative care or metabolic optimization. Studies limited to outpatient diabetes management without relevance to surgical or perioperative physiology were excluded unless they provided mechanistic insights applicable to perioperative metabolic regulation.
Evidence synthesis
Given the heterogeneity of the study design and conceptual focus of this review, a narrative synthesis approach was adopted. Evidence was organized within a predefined framework centered on the key domains of perioperative metabolic dysfunction, including insulin resistance, impaired metabolic flexibility, mitochondrial dysfunction, and glycemic variability.
The findings were interpreted with emphasis on their mechanistic relevance and potential impact on perioperative outcomes, particularly in relation to the optimization of prehabilitation strategies in patients with diabetes. Although a formal risk of bias assessment was not performed, priority was given to higher-quality evidence, including randomized trials and meta-analyses where available (Table 1).
Results
Limitations of conventional prehabilitation strategies in patients with diabetes
Prehabilitation has been shown to improve functional capacity and postoperative outcomes in selected surgical populations [4–7]. However, accumulating evidence indicates that its effectiveness is not uniform and may vary according to patient characteristics and baseline risk profiles [3]. This variability suggests that current multimodal strategies may not fully address the key drivers of perioperative risk in patients with diabetes.
This limitation is particularly evident in patients with diabetes. Despite the implementation of prehabilitation and ERAS pathways [20], patients with diabetes continue to experience higher rates of postoperative complications compared with those without diabetes [1,2]. These findings indicate that conventional optimization strategies may be insufficient for this high-risk population.
A central explanation lies in diabetes-related metabolic dysfunction. Patients with diabetes commonly exhibit persistent hyperglycemia, insulin resistance, impaired metabolic flexibility, and reduced muscle mass [9–12,15], all of which amplify the metabolic response to surgical stress and impair recovery. Importantly, current prehabilitation programs are largely based on a generalized, “one-size-fits-all” approach [3,6]. Consequently, they may not adequately target the specific metabolic disturbances that drive perioperative vulnerability to diabetes.
Taken together, these observations suggest that the limited effectiveness of prehabilitation in diabetes reflects a fundamental mismatch between intervention strategies and underlying metabolic dysfunction. In this context, the failure of prehabilitation is not simply owing to insufficient intensity or duration of intervention, but rather to the lack of mechanism-targeted approaches that address diabetes-specific metabolic risks.
Metabolic dysfunction as a therapeutic target in diabetes
A central determinant of perioperative vulnerability in patients with diabetes is impaired metabolic flexibility that is defined as the reduced ability to switch between lipid and carbohydrate oxidation in response to physiological demand [8–10]. This impairment reflects the underlying mitochondrial dysfunction and disordered substrate utilization, limiting the capacity to maintain energy homeostasis during surgical stress. As a result, patients with diabetes exhibit reduced metabolic adaptability during the perioperative period that has been associated with increased postoperative morbidity [11].
This baseline metabolic impairment is further exacerbated by the surgical stress response. Perioperative insulin resistance leads to increased hepatic glucose production, hyperglycemia, and accelerated protein catabolism [1]. Simultaneously, chronic low-grade inflammation is amplified, contributing to immune dysfunction, impaired wound healing, and tissue injury [1,2]. These processes interact to create a self-sustaining cycle of hyperglycemia, inflammation, and metabolic dysfunction that contributes to perioperative instability and delayed recovery.
Additional contributors to perioperative risk are anabolic resistance and loss of skeletal muscle mass. Reduced responsiveness to nutritional stimuli limits protein synthesis and promotes muscle loss, particularly in the context of surgical stress and during reduced mobility [14,15]. Because the skeletal muscle plays a key role in glucose disposal and metabolic regulation, the loss of muscle mass further worsens insulin resistance and metabolic control [21].
Collectively, impaired metabolic flexibility, insulin resistance, mitochondrial dysfunction, inflammation, and anabolic resistance represent interconnected mechanisms that underlie the perioperative risk of diabetes. These domains define key therapeutic targets for diabetes-specific prehabilitation.
From a clinical perspective, insulin resistance and glycemic instability remain the primary targets of intervention. Poor glycemic control is consistently associated with increased postoperative complications, including infection, impaired wound healing, and prolonged hospitalization [1,2]. Importantly, glycemic variability beyond average glucose levels contributes to oxidative stress, endothelial dysfunction, and immune impairment [22]. Therefore, perioperative strategies should prioritize glucose control and the stabilization of glycemic fluctuations.
Mitochondrial dysfunction represents a complementary target because improving oxidative capacity may enhance metabolic flexibility and support the physiological response to surgical stress [8–10]. In parallel, the modulation of inflammatory pathways is essential, given the bidirectional relationship between inflammation and metabolic dysregulation.
CGM offers a practical tool for operationalizing these targets in clinical practice. By enabling real-time evaluation of glucose dynamics, CGM facilitates early detection of glycemic excursions and supports more precise and adaptive metabolic management during the prehabilitation period [16,23].
Overall, these findings support the shift from isolated glycemic control toward the coordinated management of interconnected metabolic pathways. Targeting insulin resistance, mitochondrial function, inflammation, and anabolic capacity may provide a more clinically effective and mechanism-aligned approach to improve perioperative outcomes in patients with diabetes.
Mechanism-aligned prehabilitation strategies
Targeted metabolic optimization in patients with diabetes requires an explicit alignment of interventions with the underlying metabolic disturbances described above. Rather than applying uniform multimodal strategies, prehabilitation should be structured to address specific domains of metabolic dysfunction within perioperative pathways such as ERAS [20]. This approach enables a more mechanism-informed strategy to improve perioperative resilience (Fig. 1, Table 2).
Mechanism-based Mapping of Metabolic Targets to Prehabilitation Interventions in Patients with Diabetes
Exercise-based conditioning
Exercise is a core intervention that directly targets insulin resistance and mitochondrial dysfunction. Combined aerobic and resistance training improves insulin sensitivity, enhances glucose uptake by skeletal muscle, and promotes mitochondrial biogenesis, thereby supporting metabolic flexibility [8,12]. These effects are particularly relevant in patients with diabetes given the high prevalence of reduced cardiorespiratory fitness, muscle loss, and impaired metabolic adaptability.
Therefore, exercise prescriptions should be individualized. Autonomic dysfunction may blunt heart rate responses and glycemic fluctuations may occur during physical activity. Accordingly, integrating perceived exertion with CGM provides a practical approach to tailoring exercise intensity while maintaining metabolic safety [17,18]. Modified or low-load exercise strategies may be required in patients with neuropathy, frailty, or musculoskeletal limitations. Overall, exercise-based conditioning serves as a central component of metabolic optimization by targeting key mechanisms underlying perioperative risk.
Nutritional optimization
Nutritional strategies primarily target anabolic resistance and loss of skeletal muscle mass while also influencing glycemic stability. Adequate protein and total caloric intakes are essential for supporting muscle protein synthesis, preserving lean mass, and facilitating recovery [14,15]. This is particularly important in patients with diabetes, in whom sarcopenia and reduced physiological reserves are common contributors to perioperative vulnerability.
Anabolic resistance remains a key barrier to effective nutritional interventions. In this context, anabolic supplementation such as β-hydroxy β-methylbutyrate (HMB) may enhance muscle preservation and support recovery in metabolically vulnerable patients. Nutritional strategies should also be individualized according to comorbidities [14,15]. For example, diabetic kidney disease may require the adjustment of protein intake, whereas autonomic neuropathy may affect tolerance to feeding strategies.
Beyond macronutrient provision, dietary planning should aim to minimize glycemic variability. When combined with CGM, structured nutrition can support more stable glucose profiles and facilitate safer integration with exercise-based prehabilitation.
Glycemic optimization
The optimization of glycemic control is a central component of metabolic management in patients with diabetes undergoing surgery. Poor glycemic control is consistently associated with increased postoperative complications, including infection, impaired wound healing, cardiovascular events, and prolonged hospitalization [1,2]. In addition to chronic hyperglycemia, glycemic variability plays a critical role in oxidative stress, endothelial dysfunction, and immune impairment [22].
Accordingly, glycemic optimization should extend beyond static measures of glucose control to include the stabilization of glucose dynamics. CGM enables real-time assessment of glucose patterns, facilitating individualized adjustment of diet, physical activity, and glucose-lowering therapy [16–18]. This approach supports the early detection of hyperglycemia and hypoglycemia and enhances the safety and effectiveness of prehabilitation interventions.
Preoperative carbohydrate loading, traditionally avoided in diabetes, has recently been reconsidered in the ERAS pathways. Although evidence remains limited, carefully selected patients with type 2 diabetes may tolerate controlled carbohydrate administration when combined with appropriate monitoring and medication adjustment [20,24].
Pharmacological modulation
Pharmacological strategies provide additional means of targeting metabolic dysfunction. Metformin exerts pleiotropic effects beyond glucose lowering, including the activation of AMP-activated protein kinase, modulation of mitochondrial function, and attenuation of inflammatory pathways [19]. These properties suggest that metformin is a potential modulator of key mechanisms underlying perioperative metabolic dysfunction.
Other agents, including sodium–glucose cotransporter 2 (SGLT2) inhibitors and incretin-based therapies, also have metabolic and anti-inflammatory effects that may support metabolic stability. However, perioperative use requires careful consideration. SGLT2 inhibitors are associated with a risk of euglycemic ketoacidosis, and glucagon-like peptide-1 receptor agonists may delay gastric emptying, with implications for perioperative management [16,25].
Overall, pharmacological optimization should be integrated with exercise, nutritional strategies, and CGM-guided glycemic management to achieve a coordinated metabolic control.
Integration within a mechanism-based framework
Collectively, these interventions highlight that effective prehabilitation in diabetes requires coordinated targeting of interconnected metabolic pathways rather than isolated interventions. Exercise, nutrition, glycemic management, and pharmacological strategies should be integrated to address insulin resistance, mitochondrial dysfunction, inflammation, and anabolic impairment in a complementary manner.
This mechanism-aligned approach provides a clinically applicable framework for improving perioperative outcomes in patients with diabetes and supports a shift from generalized multimodal prehabilitation toward targeted metabolic optimization.
Individualized prehabilitation based on metabolic profiles
The effectiveness of prehabilitation in patients with diabetes is closely linked to the degree to which interventions are aligned with dominant metabolic disturbances. Building on the mechanism-based framework outlined above, a uniform approach is unlikely to be optimal, given the heterogeneity of metabolic dysfunction in this population [8–11]. Instead, prehabilitation should be individualized according to the predominant metabolic and functional features that drive perioperative risk in each patient.
Patients with relatively stable glycemic control and preserved metabolic reserve may be managed with standard multimodal prehabilitation, including exercise-based conditioning, nutritional support, and general optimization of glycemic control [6,7]. In this group, the primary objective was to maintain metabolic stability while preserving functional capacity.
In contrast, patients with pronounced insulin resistance may require more targeted strategies to improve their insulin sensitivity and metabolic adaptability. Combined aerobic and resistance training can be complemented by pharmacological approaches, such as metformin [12,19], and supported by CGM-guided glycemic management to reduce variability in glucose levels and improve metabolic stability [16–18].
Patients with reduced muscle mass or an impaired functional reserve represent another high-risk subgroup. In these individuals, the preservation of skeletal muscle is a key priority. Nutritional strategies emphasizing adequate protein intake and anabolic supplementation together with resistance-based exercise may help counteract anabolic resistance and support functional recovery.
Finally, patients with significant glycemic variability may benefit from strategies that focus on stabilizing glucose dynamics. CGM plays a central role in this context by enabling real-time detection of glycemic excursions and facilitating individualized adjustments in diet, physical activity, and glucose-lowering therapy [16–18].
Overall, these considerations support a shift from uniform multimodal prehabilitation toward an individualized, mechanism-informed approach based on dominant metabolic features. This strategy is consistent with the concept of targeted metabolic optimization and provides a practical framework for improving the perioperative outcomes in patients with diabetes. Table 3 presents a clinical checklist to guide diabetes-specific prehabilitation, facilitating the translation of this approach into routine perioperative care.
Integration into perioperative pathways: linking prehabilitation with ERAS
The effectiveness of diabetes-specific prehabilitation depends on targeted interventions and their integration into perioperative care pathways. ERAS provides a structured framework to attenuate surgical stress and support recovery; however, standard pathways may not fully account for the metabolic complexity of diabetes [20].
Prehabilitation and ERAS should be considered complementary strategies across the perioperative continuum. Prehabilitation addresses baseline metabolic dysfunction, whereas ERAS focuses on modulating the perioperative stress response. In patients with diabetes, these phases are closely interdependent, because unresolved metabolic disturbances may reduce the effectiveness of ERAS interventions [1,2].
Effective integration requires alignment of mechanism-based prehabilitation with core ERAS elements. Preoperative stabilization of glycemic control and variability may support early nutrition and mobilization, whereas exercise- and nutrition-based interventions enhance tolerance to surgical stress and recovery [12–15]. CGM provides a practical bridge across phases by enabling individualized metabolic management and improving the detection of glycemic excursions during the perioperative period [16–18,26].
Integration into ERAS requires a shift from standardized protocols toward individualized strategies guided by dominant metabolic features. In patients with significant metabolic impairment, this necessitates tailored modifications of conventional ERAS components according to key vulnerabilities, including insulin resistance, sarcopenia, and glycemic instability.
Although direct evidence supporting diabetes-specific prehabilitation within ERAS remains limited, accumulating mechanistic insights provide a strong physiological rationale for this approach. These insights support a transition from generic multimodal pathways to targeted, mechanism-based optimization strategies.
From an anesthetic perspective, this framework centers on CGM-guided dynamic glycemic management and prioritizing the reduction of glycemic variability rather than strict normalization. Building on this metabolic foundation, targeted exercise and nutritional optimization serve to enhance metabolic resilience and support recovery. ERAS components should therefore be implemented in a risk-adapted manner, aligned with the patient’s dominant metabolic features.
Discussion
Major surgery imposes a substantial metabolic demand, requiring the coordinated regulation of glucose homeostasis, substrate utilization, and inflammatory responses. In patients with diabetes, impaired metabolic flexibility, mitochondrial dysfunction, and reduced insulin sensitivity compromise this adaptive response, and are associated with increased perioperative morbidity [1,8–11]. These observations support a shift in perspective, recognizing diabetes not simply as a comorbidity, but as a modifier of perioperative physiology that necessitates targeted metabolic optimization.
The limited effectiveness of conventional prehabilitation in this population may be explained by a “metabolic mismatch,” whereby generalized multimodal strategies fail to address the dominant drivers of perioperative risk. Instead a mechanism-based approach emphasizes the alignment of interventions with the key domains of dysfunction and provides a biologically grounded framework for more targeted perioperative care.
From a clinical perspective, this framework can be translated into structured domain-based assessments and interventions. The evaluation should focus on key metabolic and functional domains, including glycemic control, insulin resistance, muscle status, and overall functional capacity. Corresponding strategies should prioritize glycemic stability rather than strict normalization, integrate aerobic and resistance exercises to improve metabolic function, and incorporate nutritional support to address anabolic impairments. This approach enables a more direct link between the underlying pathophysiology and therapeutic intervention and supports its implementation in routine practice.
The CGM plays a central role in the operationalization of this strategy. By providing real-time assessment of glucose dynamics, CGM facilitates individualized adjustment of diet, physical activity, and pharmacological therapy. Importantly, this review highlights the clinical relevance of glycemic variability, reinforcing the need for dynamic rather than static approaches to glycemic management [16,23].
The integration of these strategies within established perioperative pathways, such as ERAS, provides a pragmatic route for clinical implementation. Aligning mechanism-based prehabilitation with ERAS enables coordinated delivery of metabolic optimization throughout the perioperative continuum and may enhance the effectiveness of both approaches.
Despite these conceptual advances, important gaps in evidence remain. Future research should focus on individualized, mechanism-informed prehabilitation strategies and evaluate their impact in prospective trials. Furthermore, the role of CGM-integrated care, utility of pragmatic metabolic biomarkers (e.g., Homeostatic Model Assessment for Insulin Resistance [HOMA-IR], triglyceride–glucose index [TyG index], and CGM-derived metrics), and perioperative effects of pharmacological modulation require further investigation [27–29]. Addressing these gaps is essential for translating mechanism-based metabolic optimization into improved surgical outcomes in patients with diabetes.
Prehabilitation in patients with diabetes should move beyond generalized multimodal strategies toward targeted metabolic optimization aligned with the underlying pathophysiology. A mechanism-informed approach integrating exercise, nutrition, glycemic management, and pharmacological modulation offers a more precise and clinically relevant framework for improving perioperative outcomes. Embedding these strategies within established pathways, such as ERAS, may enhance their effectiveness and facilitate their implementation in routine practice. Future studies are needed to validate this integrated approach and define its impact on surgical outcomes in patients with diabetes.
Notes
Acknowledgements
The authors used a generative artificial intelligence (AI) tool (ChatGPT, OpenAI) to assist in language editing, structural refinement, and clarity of expression during manuscript preparation. All content was critically reviewed and approved by the authors, who take full responsibility for the accuracy and integrity of the work.
Funding
None.
Conflicts of Interest
No potential conflict of interest relevant to this article was reported.
Data Availability
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
Author Contributions
Youn Yi Jo (Data curation; Investigation; Validation; Writing – review & editing)
Jung Ju Choi (Investigation; Validation; Writing – review & editing)
Chun Gon Park (Visualization; Writing – review & editing)
Ga Hee Kim (Investigation; Writing – review & editing)
Hyun Jeong Kwak (Conceptualization; Project administration; Writing – original draft; Writing – review & editing)
